UK’s ThinCats Reportedly Deployed £300M in Funding to SMEs in Past Year

As the year 2025 finally draws to a close, UK’s ThinCats says that is an opportune moment to carefully reflect on what they claim to have achieved together, along with their customers, introducers and colleagues, and how they now continue to support the growth of mid-sized businesses currently operating across the United Kingdom.

During the past year, ThinCats reports that it has deployed more than £300 million in funding to mid-sized SMEs nationwide, “helping businesses invest, grow and navigate an evolving economic environment.”

According to the update from ThinCats, a significant part of this included over £100 million in “follow-on funding, reinforcing their commitment to long-term partnerships and continued support for existing customers.”

ThinCats further stated that their position for funding M&A transactions was recognised nationally, reportedly ranking as one of the reliable alternative debt providers by volume in the UK in Experian‘s Q3YTD MarketIQ report.

The company claims that this may serve as a testament to the strength of their proposition and the trust placed in them by UK based borrowers and advisers alike.

ThinCats also mentioned that product development remained a key focus area in 2025.

This past year saw the launch of Vision360, which is described by ThinCats in a blog post as their proprietary borrower management tool, designed to give professionals teams a deeper, “clearer understanding of each customer’s individual journey.”

ThinCats added that they have also introduced Growth Lens, using their data analytics capability, the report provides insights “into growth trends within the UK’s mid-sized business population.”

It was also a year to acknowledge the efforts and consistent contributions of their professional team members.

Beyond just funding, ThinCats said that their professional teams came together to make a positive impact, raising more than £30,000 for charitable causes in support of Parkinsons’s UK and Macmillan Cancer Support.

As the look ahead to 2026, their main focus remains unchanged: building lasting relationships, providing flexible funding, and “continuing to evolve how they support the UK’s mid-sized businesses.”



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Oct 22, 2026 vs Jan 1, 2025 - Oct 22, 2025

Share this graph
Number of Filings131Prior 125 +4.8%
Target Raise, Total$3.40BPrior $3.54B -3.9%
This YTDYear priorChange
Filings 131 125 +4.8%
Target raise $3.40B $3.54B -3.9%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Newest
Oldest Most Voted
 
0
Would love your thoughts, please comment.x
()
x
Send this to a friend